Last 12 months
Inside the activity.
0 purchase rows · 17 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 09, 2020 Filed Dec 10, 2020 00:54 UTC |
Rhodes Jason PDirector
|
SaleCommon Stock | 7,330 | $44.69 | $327,577.70 |
DisclosureSEC source: 0001209191-20-062624 · doc4.xml · nonDerivative · entry 18 Rhodes Jason P · CIK 0001577014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,386,172 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.07 to $45.06 inclusive. F3 · balance_after: The shares reported herein give effect to the pro rata distribution of shares by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X") for no additional consideration to its limited and general partner, Atlas Venture Associates X, L.P. ("AVA X LP") subsequent to the Reporting Person's last Section 16 filing reporting ownership of the Issuer's Common Stock. As the distributions of such shares constituted only a change in the form of the Reporting Person's indirect ownership in such shares, the Reporting Person was not required to report these distributions pursuant to Section 16. F4 · ownership.nature: The shares are held directly by Atlas Venture Fund X. The general partner of Atlas Venture Fund X is AVA X LP. Atlas Venture Associates X, LLC ("AVA X LLC") is the general partner of AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims beneficial ownership of such securities held by Atlas Venture Fund X, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 09, 2020 Filed Dec 10, 2020 00:54 UTC |
Rhodes Jason PDirector
|
SaleCommon Stock | 17,883 | $43.36 | $775,406.88 |
DisclosureSEC source: 0001209191-20-062624 · doc4.xml · nonDerivative · entry 17 Rhodes Jason P · CIK 0001577014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,393,502 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.97 to $43.94 inclusive. F3 · balance_after: The shares reported herein give effect to the pro rata distribution of shares by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X") for no additional consideration to its limited and general partner, Atlas Venture Associates X, L.P. ("AVA X LP") subsequent to the Reporting Person's last Section 16 filing reporting ownership of the Issuer's Common Stock. As the distributions of such shares constituted only a change in the form of the Reporting Person's indirect ownership in such shares, the Reporting Person was not required to report these distributions pursuant to Section 16. F4 · ownership.nature: The shares are held directly by Atlas Venture Fund X. The general partner of Atlas Venture Fund X is AVA X LP. Atlas Venture Associates X, LLC ("AVA X LLC") is the general partner of AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims beneficial ownership of such securities held by Atlas Venture Fund X, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 09, 2020 Filed Dec 10, 2020 00:54 UTC |
Rhodes Jason PDirector
|
SaleCommon Stock | 1,745 | $42.51 | $74,179.95 |
DisclosureSEC source: 0001209191-20-062624 · doc4.xml · nonDerivative · entry 16 Rhodes Jason P · CIK 0001577014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,411,385 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.95 to $42.91 inclusive. F3 · balance_after: The shares reported herein give effect to the pro rata distribution of shares by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X") for no additional consideration to its limited and general partner, Atlas Venture Associates X, L.P. ("AVA X LP") subsequent to the Reporting Person's last Section 16 filing reporting ownership of the Issuer's Common Stock. As the distributions of such shares constituted only a change in the form of the Reporting Person's indirect ownership in such shares, the Reporting Person was not required to report these distributions pursuant to Section 16. F4 · ownership.nature: The shares are held directly by Atlas Venture Fund X. The general partner of Atlas Venture Fund X is AVA X LP. Atlas Venture Associates X, LLC ("AVA X LLC") is the general partner of AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims beneficial ownership of such securities held by Atlas Venture Fund X, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 09, 2020 Filed Dec 12, 2020 02:00 UTC |
Astley-Sparke PhilipDirector · Chief Executive Officer
|
SaleCommon Stock | 800 | $42.03 | $33,624.00 |
DisclosureSEC source: 0001104659-20-134933 · tm2038101-4_4seq1.xml · nonDerivative · entry 5 Astley-Sparke Philip · CIK 0001376491 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,330,297 F1 · kind: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on November 6, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F6 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.29 to $41.78. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| December 09, 2020 Filed Dec 12, 2020 02:00 UTC |
Astley-Sparke PhilipDirector · Chief Executive Officer
|
SaleCommon Stock | 11,116 | $43.09 | $478,988.44 |
DisclosureSEC source: 0001104659-20-134933 · tm2038101-4_4seq1.xml · nonDerivative · entry 4 Astley-Sparke Philip · CIK 0001376491 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,331,097 F1 · kind: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on November 6, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F5 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.40 to $42.48. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| December 09, 2020 Filed Dec 12, 2020 02:00 UTC |
Astley-Sparke PhilipDirector · Chief Executive Officer
|
SaleCommon Stock | 6,459 | $43.88 | $283,420.92 |
DisclosureSEC source: 0001104659-20-134933 · tm2038101-4_4seq1.xml · nonDerivative · entry 3 Astley-Sparke Philip · CIK 0001376491 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,342,213 F1 · kind: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on November 6, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F4 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.40 to $43.42. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| December 09, 2020 Filed Dec 12, 2020 02:00 UTC |
Astley-Sparke PhilipDirector · Chief Executive Officer
|
SaleCommon Stock | 6,025 | $44.85 | $270,221.25 |
DisclosureSEC source: 0001104659-20-134933 · tm2038101-4_4seq1.xml · nonDerivative · entry 2 Astley-Sparke Philip · CIK 0001376491 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,348,672 F1 · kind: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on November 6, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F3 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.40 to $44.41. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| December 09, 2020 Filed Dec 12, 2020 02:00 UTC |
Astley-Sparke PhilipDirector · Chief Executive Officer
|
SaleCommon Stock | 600 | $45.79 | $27,474.00 |
DisclosureSEC source: 0001104659-20-134933 · tm2038101-4_4seq1.xml · nonDerivative · entry 1 Astley-Sparke Philip · CIK 0001376491 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,354,697 F1 · kind: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on November 6, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F2 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.47 to $45.56. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| December 09, 2020 Filed Dec 11, 2020 21:00 UTC |
Love ColinChief Operating Officer
|
SaleCommon Stock | 1,000 | $41.97 | $41,970.00 |
DisclosureSEC source: 0001104659-20-134932 · tm2038101-3_4seq1.xml · nonDerivative · entry 5 Love Colin · CIK 0001376493 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 976,524 F1 · kind: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F6 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.28 to $41.65. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. F7 · balance_after: Following the sales reported on this Form 4, the reporting person continues to beneficially own 976,524 shares of the Issuer's common stock. The reporting person also holds options to acquire 444,653 shares of the Issuer's common stock, 215,521 of which are exercisable as of the date hereof. Read SEC document |
| December 09, 2020 Filed Dec 11, 2020 21:00 UTC |
Love ColinChief Operating Officer
|
SaleCommon Stock | 13,750 | $43.10 | $592,625.00 |
DisclosureSEC source: 0001104659-20-134932 · tm2038101-3_4seq1.xml · nonDerivative · entry 4 Love Colin · CIK 0001376493 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 977,524 F1 · kind: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F5 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.37 to $42.48. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| December 09, 2020 Filed Dec 11, 2020 21:00 UTC |
Love ColinChief Operating Officer
|
SaleCommon Stock | 7,058 | $43.90 | $309,846.20 |
DisclosureSEC source: 0001104659-20-134932 · tm2038101-3_4seq1.xml · nonDerivative · entry 3 Love Colin · CIK 0001376493 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 991,274 F1 · kind: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F4 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.37 to $43.39. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| December 09, 2020 Filed Dec 11, 2020 21:00 UTC |
Love ColinChief Operating Officer
|
SaleCommon Stock | 7,492 | $44.83 | $335,866.36 |
DisclosureSEC source: 0001104659-20-134932 · tm2038101-3_4seq1.xml · nonDerivative · entry 2 Love Colin · CIK 0001376493 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 998,332 F1 · kind: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F3 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.38 to $44.40. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| December 09, 2020 Filed Dec 11, 2020 21:00 UTC |
Love ColinChief Operating Officer
|
SaleCommon Stock | 700 | $45.82 | $32,074.00 |
DisclosureSEC source: 0001104659-20-134932 · tm2038101-3_4seq1.xml · nonDerivative · entry 1 Love Colin · CIK 0001376493 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,005,824 F1 · kind: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F2 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.47 to $45.56. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 00:50 UTC |
SLATTERY JOSEPH PDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,200 | $0.00 Strike: $3.30 | $0.00 |
DisclosureSEC source: 0001104659-20-133815 · tm2038101-2_4seq1.xml · derivative · entry 3 SLATTERY JOSEPH P · CIK 0001246530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,640 Underlying: Common Stock · 5,200 shares Expires 2027-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the shares underlying this stock option vested on October 1, 2018 and the remainder of the shares underlying this stock option vest in 36 equal monthly installments thereafter. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 00:50 UTC |
SLATTERY JOSEPH PDirector
|
SaleCommon stock | 5,200 | $46.00 | $239,200.00 |
DisclosureSEC source: 0001104659-20-133815 · tm2038101-2_4seq1.xml · nonDerivative · entry 2 SLATTERY JOSEPH P · CIK 0001246530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,667 Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 00:50 UTC |
SLATTERY JOSEPH PDirector
|
Exercise / conversionCommon Stock | 5,200 | $3.30 | $17,160.00 |
DisclosureSEC source: 0001104659-20-133815 · tm2038101-2_4seq1.xml · nonDerivative · entry 1 SLATTERY JOSEPH P · CIK 0001246530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,867 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 00:54 UTC |
Rhodes Jason PDirector
|
SaleCommon Stock | 2,869 | $46.94 | $134,670.86 |
DisclosureSEC source: 0001209191-20-062624 · doc4.xml · nonDerivative · entry 15 Rhodes Jason P · CIK 0001577014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 32,234 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.55 to $47.45 inclusive. F3 · balance_after: The shares reported herein give effect to the pro rata distribution of shares by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X") for no additional consideration to its limited and general partner, Atlas Venture Associates X, L.P. ("AVA X LP") subsequent to the Reporting Person's last Section 16 filing reporting ownership of the Issuer's Common Stock. As the distributions of such shares constituted only a change in the form of the Reporting Person's indirect ownership in such shares, the Reporting Person was not required to report these distributions pursuant to Section 16. F11 · ownership.nature: The shares are held directly by AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims beneficial ownership of such securities held by AVA X LP, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 00:54 UTC |
Rhodes Jason PDirector
|
SaleCommon Stock | 606 | $46.02 | $27,888.12 |
DisclosureSEC source: 0001209191-20-062624 · doc4.xml · nonDerivative · entry 14 Rhodes Jason P · CIK 0001577014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 35,103 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.52 to $46.42 inclusive. F3 · balance_after: The shares reported herein give effect to the pro rata distribution of shares by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X") for no additional consideration to its limited and general partner, Atlas Venture Associates X, L.P. ("AVA X LP") subsequent to the Reporting Person's last Section 16 filing reporting ownership of the Issuer's Common Stock. As the distributions of such shares constituted only a change in the form of the Reporting Person's indirect ownership in such shares, the Reporting Person was not required to report these distributions pursuant to Section 16. F11 · ownership.nature: The shares are held directly by AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims beneficial ownership of such securities held by AVA X LP, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 00:54 UTC |
Rhodes Jason PDirector
|
SaleCommon Stock | 45,027 | $46.89 | $2,111,316.03 |
DisclosureSEC source: 0001209191-20-062624 · doc4.xml · nonDerivative · entry 13 Rhodes Jason P · CIK 0001577014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,003,356 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.55 to $47.45 inclusive. F8 · ownership.nature: The shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Venture Opportunity Fund I"). The general partner of Atlas Venture Opportunity Fund I is Atlas Venture Associates Opportunity I, L.P. ("AVAO I LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO I LLC") is the general partner of AVAO I LP. The Reporting Person is a member of AVAO I LLC and disclaims beneficial ownership of such securities held by Atlas Venture Opportunity Fund I, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 00:54 UTC |
Rhodes Jason PDirector
|
SaleCommon Stock | 19,620 | $46.14 | $905,266.80 |
DisclosureSEC source: 0001209191-20-062624 · doc4.xml · nonDerivative · entry 12 Rhodes Jason P · CIK 0001577014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,048,383 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.52 to $46.42 inclusive. F8 · ownership.nature: The shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Venture Opportunity Fund I"). The general partner of Atlas Venture Opportunity Fund I is Atlas Venture Associates Opportunity I, L.P. ("AVAO I LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO I LLC") is the general partner of AVAO I LP. The Reporting Person is a member of AVAO I LLC and disclaims beneficial ownership of such securities held by Atlas Venture Opportunity Fund I, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 00:54 UTC |
Rhodes Jason PDirector
|
SaleCommon Stock | 33,133 | $46.94 | $1,555,263.02 |
DisclosureSEC source: 0001209191-20-062624 · doc4.xml · nonDerivative · entry 11 Rhodes Jason P · CIK 0001577014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,413,130 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.55 to $47.45 inclusive. F3 · balance_after: The shares reported herein give effect to the pro rata distribution of shares by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X") for no additional consideration to its limited and general partner, Atlas Venture Associates X, L.P. ("AVA X LP") subsequent to the Reporting Person's last Section 16 filing reporting ownership of the Issuer's Common Stock. As the distributions of such shares constituted only a change in the form of the Reporting Person's indirect ownership in such shares, the Reporting Person was not required to report these distributions pursuant to Section 16. F4 · ownership.nature: The shares are held directly by Atlas Venture Fund X. The general partner of Atlas Venture Fund X is AVA X LP. Atlas Venture Associates X, LLC ("AVA X LLC") is the general partner of AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims beneficial ownership of such securities held by Atlas Venture Fund X, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 00:54 UTC |
Rhodes Jason PDirector
|
SaleCommon Stock | 7,001 | $46.02 | $322,186.02 |
DisclosureSEC source: 0001209191-20-062624 · doc4.xml · nonDerivative · entry 10 Rhodes Jason P · CIK 0001577014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,446,263 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.52 to $46.42 inclusive. F3 · balance_after: The shares reported herein give effect to the pro rata distribution of shares by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X") for no additional consideration to its limited and general partner, Atlas Venture Associates X, L.P. ("AVA X LP") subsequent to the Reporting Person's last Section 16 filing reporting ownership of the Issuer's Common Stock. As the distributions of such shares constituted only a change in the form of the Reporting Person's indirect ownership in such shares, the Reporting Person was not required to report these distributions pursuant to Section 16. F4 · ownership.nature: The shares are held directly by Atlas Venture Fund X. The general partner of Atlas Venture Fund X is AVA X LP. Atlas Venture Associates X, LLC ("AVA X LLC") is the general partner of AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims beneficial ownership of such securities held by Atlas Venture Fund X, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 00:48 UTC |
Dhingra KapilDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $1.75 | $0.00 |
DisclosureSEC source: 0001104659-20-133812 · tm2038101-1_4seq1.xml · derivative · entry 5 Dhingra Kapil · CIK 0001456849 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,169 Underlying: Common Stock · 40,000 shares Expires 2026-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares underlying this option vested on January 21, 2016. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 00:48 UTC |
Dhingra KapilDirector
|
SaleCommon Stock | 1,802 | $47.04 | $84,766.08 |
DisclosureSEC source: 0001104659-20-133812 · tm2038101-1_4seq1.xml · nonDerivative · entry 4 Dhingra Kapil · CIK 0001456849 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.85 to $47.21. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 00:48 UTC |
Dhingra KapilDirector
|
SaleCommon Stock | 13,523 | $46.22 | $625,033.06 |
DisclosureSEC source: 0001104659-20-133812 · tm2038101-1_4seq1.xml · nonDerivative · entry 3 Dhingra Kapil · CIK 0001456849 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,802 F2 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.85 to $46.84. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 00:48 UTC |
Dhingra KapilDirector
|
SaleCommon Stock | 24,675 | $45.09 | $1,112,595.75 |
DisclosureSEC source: 0001104659-20-133812 · tm2038101-1_4seq1.xml · nonDerivative · entry 2 Dhingra Kapil · CIK 0001456849 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,325 F1 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.84 to $45.82. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 00:48 UTC |
Dhingra KapilDirector
|
Exercise / conversionCommon Stock | 40,000 | $1.75 | $70,000.00 |
DisclosureSEC source: 0001104659-20-133812 · tm2038101-1_4seq1.xml · nonDerivative · entry 1 Dhingra Kapil · CIK 0001456849 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 00:54 UTC |
Rhodes Jason PDirector
|
SaleCommon Stock | 106 | $46.91 | $4,972.46 |
DisclosureSEC source: 0001209191-20-062624 · doc4.xml · nonDerivative · entry 9 Rhodes Jason P · CIK 0001577014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 35,709 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.71 to $47.19 inclusive. F3 · balance_after: The shares reported herein give effect to the pro rata distribution of shares by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X") for no additional consideration to its limited and general partner, Atlas Venture Associates X, L.P. ("AVA X LP") subsequent to the Reporting Person's last Section 16 filing reporting ownership of the Issuer's Common Stock. As the distributions of such shares constituted only a change in the form of the Reporting Person's indirect ownership in such shares, the Reporting Person was not required to report these distributions pursuant to Section 16. F11 · ownership.nature: The shares are held directly by AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims beneficial ownership of such securities held by AVA X LP, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 00:54 UTC |
Rhodes Jason PDirector
|
SaleCommon Stock | 2,007 | $45.97 | $92,261.79 |
DisclosureSEC source: 0001209191-20-062624 · doc4.xml · nonDerivative · entry 8 Rhodes Jason P · CIK 0001577014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 35,815 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.71 to $46.67 inclusive. F3 · balance_after: The shares reported herein give effect to the pro rata distribution of shares by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X") for no additional consideration to its limited and general partner, Atlas Venture Associates X, L.P. ("AVA X LP") subsequent to the Reporting Person's last Section 16 filing reporting ownership of the Issuer's Common Stock. As the distributions of such shares constituted only a change in the form of the Reporting Person's indirect ownership in such shares, the Reporting Person was not required to report these distributions pursuant to Section 16. F11 · ownership.nature: The shares are held directly by AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims beneficial ownership of such securities held by AVA X LP, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 00:54 UTC |
Rhodes Jason PDirector
|
SaleCommon Stock | 748 | $45.46 | $34,004.08 |
DisclosureSEC source: 0001209191-20-062624 · doc4.xml · nonDerivative · entry 7 Rhodes Jason P · CIK 0001577014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 37,822 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.71 to $45.708 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (9), (10), (12), (13), (14), (15), (16) and (17). F3 · balance_after: The shares reported herein give effect to the pro rata distribution of shares by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X") for no additional consideration to its limited and general partner, Atlas Venture Associates X, L.P. ("AVA X LP") subsequent to the Reporting Person's last Section 16 filing reporting ownership of the Issuer's Common Stock. As the distributions of such shares constituted only a change in the form of the Reporting Person's indirect ownership in such shares, the Reporting Person was not required to report these distributions pursuant to Section 16. F11 · ownership.nature: The shares are held directly by AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims beneficial ownership of such securities held by AVA X LP, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 00:54 UTC |
Rhodes Jason PDirector
|
SaleCommon Stock | 2,322 | $46.93 | $108,971.46 |
DisclosureSEC source: 0001209191-20-062624 · doc4.xml · nonDerivative · entry 6 Rhodes Jason P · CIK 0001577014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,068,003 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.71 to $47.23 inclusive. F8 · ownership.nature: The shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Venture Opportunity Fund I"). The general partner of Atlas Venture Opportunity Fund I is Atlas Venture Associates Opportunity I, L.P. ("AVAO I LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO I LLC") is the general partner of AVAO I LP. The Reporting Person is a member of AVAO I LLC and disclaims beneficial ownership of such securities held by Atlas Venture Opportunity Fund I, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 00:54 UTC |
Rhodes Jason PDirector
|
SaleCommon Stock | 26,713 | $46.06 | $1,230,400.78 |
DisclosureSEC source: 0001209191-20-062624 · doc4.xml · nonDerivative · entry 5 Rhodes Jason P · CIK 0001577014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,070,325 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.71 to $46.68 inclusive. F8 · ownership.nature: The shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Venture Opportunity Fund I"). The general partner of Atlas Venture Opportunity Fund I is Atlas Venture Associates Opportunity I, L.P. ("AVAO I LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO I LLC") is the general partner of AVAO I LP. The Reporting Person is a member of AVAO I LLC and disclaims beneficial ownership of such securities held by Atlas Venture Opportunity Fund I, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 00:54 UTC |
Rhodes Jason PDirector
|
SaleCommon Stock | 2,962 | $45.45 | $134,622.90 |
DisclosureSEC source: 0001209191-20-062624 · doc4.xml · nonDerivative · entry 4 Rhodes Jason P · CIK 0001577014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,097,038 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.71 to $45.70 inclusive. F8 · ownership.nature: The shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Venture Opportunity Fund I"). The general partner of Atlas Venture Opportunity Fund I is Atlas Venture Associates Opportunity I, L.P. ("AVAO I LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO I LLC") is the general partner of AVAO I LP. The Reporting Person is a member of AVAO I LLC and disclaims beneficial ownership of such securities held by Atlas Venture Opportunity Fund I, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 00:54 UTC |
Rhodes Jason PDirector
|
SaleCommon Stock | 1,222 | $46.91 | $57,324.02 |
DisclosureSEC source: 0001209191-20-062624 · doc4.xml · nonDerivative · entry 3 Rhodes Jason P · CIK 0001577014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,453,264 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.71 to $47.19 inclusive. F3 · balance_after: The shares reported herein give effect to the pro rata distribution of shares by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X") for no additional consideration to its limited and general partner, Atlas Venture Associates X, L.P. ("AVA X LP") subsequent to the Reporting Person's last Section 16 filing reporting ownership of the Issuer's Common Stock. As the distributions of such shares constituted only a change in the form of the Reporting Person's indirect ownership in such shares, the Reporting Person was not required to report these distributions pursuant to Section 16. F4 · ownership.nature: The shares are held directly by Atlas Venture Fund X. The general partner of Atlas Venture Fund X is AVA X LP. Atlas Venture Associates X, LLC ("AVA X LLC") is the general partner of AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims beneficial ownership of such securities held by Atlas Venture Fund X, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 00:54 UTC |
Rhodes Jason PDirector
|
SaleCommon Stock | 23,174 | $45.97 | $1,065,308.78 |
DisclosureSEC source: 0001209191-20-062624 · doc4.xml · nonDerivative · entry 2 Rhodes Jason P · CIK 0001577014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,454,486 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.71 to $46.67 inclusive. F3 · balance_after: The shares reported herein give effect to the pro rata distribution of shares by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X") for no additional consideration to its limited and general partner, Atlas Venture Associates X, L.P. ("AVA X LP") subsequent to the Reporting Person's last Section 16 filing reporting ownership of the Issuer's Common Stock. As the distributions of such shares constituted only a change in the form of the Reporting Person's indirect ownership in such shares, the Reporting Person was not required to report these distributions pursuant to Section 16. F4 · ownership.nature: The shares are held directly by Atlas Venture Fund X. The general partner of Atlas Venture Fund X is AVA X LP. Atlas Venture Associates X, LLC ("AVA X LLC") is the general partner of AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims beneficial ownership of such securities held by Atlas Venture Fund X, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 00:54 UTC |
Rhodes Jason PDirector
|
SaleCommon Stock | 8,636 | $45.46 | $392,592.56 |
DisclosureSEC source: 0001209191-20-062624 · doc4.xml · nonDerivative · entry 1 Rhodes Jason P · CIK 0001577014 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,477,660 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.71 to $45.708 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (9), (10), (12), (13), (14), (15), (16) and (17). F3 · balance_after: The shares reported herein give effect to the pro rata distribution of shares by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X") for no additional consideration to its limited and general partner, Atlas Venture Associates X, L.P. ("AVA X LP") subsequent to the Reporting Person's last Section 16 filing reporting ownership of the Issuer's Common Stock. As the distributions of such shares constituted only a change in the form of the Reporting Person's indirect ownership in such shares, the Reporting Person was not required to report these distributions pursuant to Section 16. F4 · ownership.nature: The shares are held directly by Atlas Venture Fund X. The general partner of Atlas Venture Fund X is AVA X LP. Atlas Venture Associates X, LLC ("AVA X LLC") is the general partner of AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims beneficial ownership of such securities held by Atlas Venture Fund X, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 20:00 UTC |
Love ColinChief Operating Officer
|
SaleCommon Stock | 3,759 | $44.41 | $166,937.19 |
DisclosureSEC source: 0001104659-20-126992 · a4.xml · nonDerivative · entry 3 Love Colin · CIK 0001376493 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,006,524 F1 · kind: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F4 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.63 to $44.05. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. F5 · balance_after: Following the sales reported on this Form 4, the reporting person continues to beneficially own 1,006,524 shares of the Issuer's common stock. The reporting person also holds options to acquire 444,653 shares of the Issuer's common stock, 208,687 of which are exercisable as of the date hereof. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 20:00 UTC |
Love ColinChief Operating Officer
|
SaleCommon Stock | 10,941 | $45.04 | $492,782.64 |
DisclosureSEC source: 0001104659-20-126992 · a4.xml · nonDerivative · entry 2 Love Colin · CIK 0001376493 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,010,283 F1 · kind: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F3 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.63 to $44.64. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 20:00 UTC |
Love ColinChief Operating Officer
|
SaleCommon Stock | 300 | $46.43 | $13,929.00 |
DisclosureSEC source: 0001104659-20-126992 · a4.xml · nonDerivative · entry 1 Love Colin · CIK 0001376493 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,021,224 F1 · kind: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F2 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.73 to $46.09. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| November 02, 2020 Filed Nov 3, 2020 21:07 UTC |
Lewis TanyaDirector
|
GrantStock Option (right to buy) · Derivative | 33,000 | $0.00 Strike: $42.00 | $0.00 |
DisclosureSEC source: 0001104659-20-120937 · a4.xml · derivative · entry 1 Lewis Tanya · CIK 0001451038 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,000 Underlying: Common Stock · 33,000 shares Expires 2030-11-02 F1 · derivative.exercise_date: 25% of the shares underlying this stock option vest on November 2, 2021, and the remainder of the shares underlying this stock option vest in 24 approximately equal monthly installments thereafter. Read SEC document |
| October 14, 2020 Filed Oct 16, 2020 22:05 UTC |
Esposito PamelaChief Business Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 16,000 | $0.00 Strike: $1.01 | $0.00 |
DisclosureSEC source: 0001104659-20-115710 · a4.xml · derivative · entry 4 Esposito Pamela · CIK 0001744425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,203 Underlying: Common Stock · 16,000 shares Expires 2025-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying the stock option have vested and are exercisable as of the date hereof. Read SEC document |
| October 14, 2020 Filed Oct 16, 2020 22:05 UTC |
Esposito PamelaChief Business Officer
|
SaleCommon Stock | 9,000 | $35.04 | $315,360.00 |
DisclosureSEC source: 0001104659-20-115710 · a4.xml · nonDerivative · entry 3 Esposito Pamela · CIK 0001744425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,700 F1 · kind: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 15, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F3 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.20. F4 · balance_after: Following the sales reported on this Form 4, the reporting person continues to beneficially own 112,700 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 577,146 shares of the Issuer's common stock, 384,273 of which are exercisable as of the date hereof. Read SEC document |
| October 14, 2020 Filed Oct 16, 2020 22:05 UTC |
Esposito PamelaChief Business Officer
|
SaleCommon Stock | 7,000 | $30.15 | $211,050.00 |
DisclosureSEC source: 0001104659-20-115710 · a4.xml · nonDerivative · entry 2 Esposito Pamela · CIK 0001744425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,700 F1 · kind: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 15, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F2 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.57. Read SEC document |
| October 14, 2020 Filed Oct 16, 2020 22:05 UTC |
Esposito PamelaChief Business Officer
|
Exercise / conversionCommon Stock | 16,000 | $1.01 | $16,160.00 |
DisclosureSEC source: 0001104659-20-115710 · a4.xml · nonDerivative · entry 1 Esposito Pamela · CIK 0001744425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 20:48 UTC |
Atlas Venture Fund X, L.P.10% owner
|
OtherCommon Stock | 445,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-050942 · doc4.xml · nonDerivative · entry 1 Atlas Venture Fund X, L.P. · CIK 0001628098 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,486,296 F1 · kind: Represent a pro rata distribution, and not a purchase or sale of securities, by Atlas Venture Fund X, L.P. to its general partner and limited partners without additional consideration. This distribution was effected pursuant to a plan adopted in accordance with Rule 10b5-1 on February 28, 2020. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 16:25 UTC |
Love ColinChief Operating Officer
|
SaleCommon Stock | 1,529 | $24.83 | $37,965.07 |
DisclosureSEC source: 0001104659-20-106117 · a4.xml · nonDerivative · entry 3 Love Colin · CIK 0001376493 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,021,524 F1 · kind: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F4 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.70 to $25.00. F5 · balance_after: Following the sales reported on this Form 4, the reporting person continues to beneficially own 1,021,524 shares of the Issuer's common stock. The reporting person also holds options to acquire 444,653 shares of the Issuer's common stock, 195,019 of which are exercisable as of the date hereof. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 16:25 UTC |
Love ColinChief Operating Officer
|
SaleCommon Stock | 10,271 | $24.11 | $247,633.81 |
DisclosureSEC source: 0001104659-20-106117 · a4.xml · nonDerivative · entry 2 Love Colin · CIK 0001376493 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,023,053 F1 · kind: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F3 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.68 to $24.67. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 16:25 UTC |
Love ColinChief Operating Officer
|
SaleCommon Stock | 3,200 | $23.09 | $73,888.00 |
DisclosureSEC source: 0001104659-20-106117 · a4.xml · nonDerivative · entry 1 Love Colin · CIK 0001376493 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,033,324 F1 · kind: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F2 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.60 to $23.57. Read SEC document |
| August 31, 2020 Filed Sep 1, 2020 21:13 UTC |
Esposito PamelaChief Business Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $1.01 | $0.00 |
DisclosureSEC source: 0001104659-20-101464 · a4.xml · derivative · entry 3 Esposito Pamela · CIK 0001744425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,203 Underlying: Common Stock · 5,000 shares Expires 2025-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying the stock option have vested and are exercisable as of the date hereof. Read SEC document |
| August 31, 2020 Filed Sep 1, 2020 21:13 UTC |
Esposito PamelaChief Business Officer
|
SaleCommon Stock | 5,000 | $27.05 | $135,250.00 |
DisclosureSEC source: 0001104659-20-101464 · a4.xml · nonDerivative · entry 2 Esposito Pamela · CIK 0001744425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,700 F1 · kind: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 15, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. F2 · price: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.18. F3 · balance_after: Following the sales reported on this Form 4, the reporting person continues to beneficially own 112,700 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 593,146 shares of the Issuer's common stock, 394,440 of which are exercisable as of the date hereof. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.